Tafasitamab for Diffuse Large B-Cell Lymphoma User Reviews
Brand names: Monjuvi
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about tafasitamab
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD19 monoclonal antibodies
- Breastfeeding
- En español
Monjuvi (tafasitamab) "Debilitating headaches, swollen extremities, hypotension, bruising. Reducing tumors, but gruelling treatment. Chemotherapy only lasted a few months. This treatment is one year minimum. Don’t think I’d do it again."